Dieter‐kurt Hossfeld
#185,219
Most Influential Person Across History
Dieter‐kurt Hossfeld's AcademicInfluence.com Rankings
Download Badge
Biology
Why Is Dieter‐kurt Hossfeld Influential?
(Suggest an Edit or Addition)Dieter‐kurt Hossfeld's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- E.S. Jaffe, N.L. Harris, H. Stein, J.W. Vardiman (eds). World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues (2002) (2687)
- The apoptosis inhibitor gene API2 and a novel 18q gene, MLT, are recurrently rearranged in the t(11;18)(q21;q21) associated with mucosa-associated lymphoid tissue lymphomas. (1999) (718)
- In vitro differentiation of endothelial cells from AC133-positive progenitor cells. (1999) (681)
- A phase 1 study of SU11248 in the treatment of patients with refractory or resistant acute myeloid leukemia (AML) or not amenable to conventional therapy for the disease. (2005) (522)
- In vitro differentiation of endothelial cells from AC133-positive progenitor cells (2000) (514)
- Vascular endothelial growth factor, a possible paracrine growth factor in human acute myeloid leukemia. (1997) (465)
- Randomized comparison of interferon-alpha with busulfan and hydroxyurea in chronic myelogenous leukemia. The German CML Study Group. (1994) (454)
- Double induction strategy for acute myeloid leukemia: the effect of high-dose cytarabine with mitoxantrone instead of standard-dose cytarabine with daunorubicin and 6-thioguanine: a randomized trial by the German AML Cooperative Group. (1999) (345)
- Tolerability-adapted imatinib 800 mg/d versus 400 mg/d versus 400 mg/d plus interferon-α in newly diagnosed chronic myeloid leukemia. (2011) (315)
- Improved outcome in adult B-cell acute lymphoblastic leukemia. (1996) (293)
- A phase 2 clinical study of SU5416 in patients with refractory acute myeloid leukemia. (2003) (279)
- Deep molecular response is reached by the majority of patients treated with imatinib, predicts survival, and is achieved more quickly by optimized high-dose imatinib: results from the randomized CML-study IV. (2014) (269)
- Randomized comparison of busulfan and hydroxyurea in chronic myelogenous leukemia: prolongation of survival by hydroxyurea. The German CML Study Group. (1993) (211)
- Phase II Clinical Trial of Titanocene Dichloride in Patients with Metastatic Breast Cancer (2000) (191)
- TNF-induced cardiomyopathy (1990) (189)
- Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants (2017) (189)
- Clinical significance of chromosomal abnormalities in acute lymphoblastic leukemia. (1984) (183)
- Immunophenotypic and genotypic features, clinical characteristics, and treatment outcome of adult pro-B acute lymphoblastic leukemia: results of the German multicenter trials GMALL 03/87 and 04/89. (1998) (178)
- Cancer-testis antigens are commonly expressed in multiple myeloma and induce systemic immunity following allogeneic stem cell transplantation. (2007) (164)
- Polymorphisms of glutathione S-transferases (GST) and thymidylate synthase (TS) – novel predictors for response and survival in gastric cancer patients (2005) (133)
- Chromosomal abnormalities and their clinical significance in acute lymphoblastic leukemia. Third International Workshop on Chromosomes in Leukemia. (1983) (130)
- A randomized multi-center phase II trial of the angiogenesis inhibitor Cilengitide (EMD 121974) and gemcitabine compared with gemcitabine alone in advanced unresectable pancreatic cancer (2006) (126)
- Drug treatment is superior to allografting as first-line therapy in chronic myeloid leukemia. (2007) (113)
- Long‐term survival of patients with acute myeloid leukemia (1997) (111)
- Results of chromosome studies and their relation to morphology, course, and prognosis in 120 patients with de novo myelodysplastic syndrome. (1990) (111)
- Expression of CEACAM1 in adenocarcinoma of the lung: a factor of independent prognostic significance. (2002) (109)
- Stromal abnormalities in neoplastic bone marrow diseases (1996) (108)
- Rapamycin inhibits proliferation and differentiation of human endothelial progenitor cells in vitro. (2004) (107)
- Analysis of concerted expression of angiogenic growth factors in acute myeloid leukemia: expression of angiopoietin-2 represents an independent prognostic factor for overall survival. (2005) (101)
- Identification of the adult human hemangioblast. (2004) (97)
- Melanoma-associated expression of vascular endothelial growth factor and its receptors FLT-1 and KDR (1999) (94)
- Karyotype in multiple myeloma and plasma cell leukaemia. (1993) (91)
- Interferon-alpha before allogeneic bone marrow transplantation in chronic myelogenous leukemia does not affect outcome adversely, provided it is discontinued at least 90 days before the procedure. (1999) (88)
- Randomized comparison of interferon α and hydroxyurea with hydroxyurea monotherapy in chronic myeloid leukemia (CML-study II): prolongation of survival by the combination of interferon α and hydroxyurea (2003) (84)
- Biliary transport of irinotecan and metabolites in normal and P-glycoprotein-deficient mice (2002) (82)
- Genetic abnormalities in chronic lymphocytic leukemia and their clinical and prognostic implications. (1997) (79)
- Gender aspects in chronic myeloid leukemia: long-term results from randomized studies (2005) (74)
- The significance of trisomy 8 in de novo acute myeloid leukaemia: the accompanying chromosome aberrations determine the prognosis (1997) (74)
- Pre-pre-B acute lymphoblastic leukemia: high frequency of alternatively spliced ALL1-AF4 transcripts and absence of minimal residual disease during complete remission. (1994) (72)
- Chromosome findings in effusions from patients with Hodgkin's disease (1978) (70)
- Lectin histochemistry of resected adenocarcinoma of the lung: helix pomatia agglutinin binding is an independent prognostic factor. (2002) (69)
- Expression of cancer-testis antigens as possible targets for antigen-specific immunotherapy in head and neck squamous cell carcinoma (2006) (68)
- Secondary malignancies in chronic myeloid leukemia patients after imatinib-based treatment: long-term observation in CML Study IV (2016) (63)
- 41.8°C whole body hyperthermia as an adjunct to chemotherapy induces prolonged T cell activation in patients with various malignant diseases (2002) (62)
- Younger patients with chronic myeloid leukemia do well in spite of poor prognostic indicators: results from the randomized CML study IV (2013) (57)
- Increase of mobilized CD34-positive peripheral blood progenitor cells in patients with Hodgkin's disease, non-Hodgkin's lymphoma, and cancer of the testis. (1996) (56)
- Comparative analysis of the impact of risk profile and of drug therapy on survival in CML using Sokal's index and a new score (1997) (55)
- Characterization of Effusion-Infiltrating T Cells (2004) (55)
- Response to chemotherapy and treating institution predict survival in primary central nervous system lymphoma (2005) (53)
- A new conditioning regimen involving total marrow irradiation, busulfan and cyclophosphamide followed by autologous PBSCT in patients with advanced multiple myeloma (2003) (47)
- Partial hepatectomy induces mobilization of a unique population of haematopoietic progenitor cells in human healthy liver donors. (2005) (47)
- Translocation (9;11)(p21;q23) in a child with acute monoblastic leukemia following 2 1/2 years after successful chemotherapy for neuroblastoma. (1986) (47)
- Pretreatment vascular endothelial growth factor (VEGF) and matrix metalloproteinase-9 (MMP-9) serum levels in patients with metastatic non-small cell lung cancer (NSCLC). (2005) (45)
- Long-term outcome of patients with newly diagnosed chronic myeloid leukemia: a randomized comparison of stem cell transplantation with drug treatment (2015) (45)
- Antiangiogenic treatment with endostatin inhibits progression of AML in vivo (2005) (44)
- PH1‐positive megakaryoblastic leukemia (1975) (44)
- Partial hepatectomy induces mobilization of a unique population of haematopoietic progenitor cells in human healthy liver donors (2005) (43)
- Chromosomal abnormality inv(3)(q21q26) associated with multilineage hematopoietic progenitor cells in hematopoietic malignancies. (1997) (42)
- Immunophenotypic and Genotypic Features , Clinical Characteristics , and Treatment Outcome of Adult ProB Acute Lymphoblastic Leukemia : Results of the German Multicenter Trials (1998) (41)
- Cytogenetic studies in 69 patients with myelodysplastic syndromes (MDS) (1987) (41)
- A novel cryptic translocation t(12;17)(p13;p12–p13) in a secondary acute myeloid leukemia results in a fusion of the ETV6 gene and the antisense strand of the PER1 gene (2003) (41)
- Whole-body hyperthermia (41.8 degrees C) combined with bimonthly oxaliplatin, high-dose leucovorin and 5-fluorouracil 48-hour continuous infusion in pretreated metastatic colorectal cancer: a phase II study. (2002) (41)
- Randomized phase II study of single-agent epirubicin +/− verapamil in patients with advanced metastatic breast cancer (1993) (40)
- Fatal pulmonary hemorrhage in patients with acute leukemia and fulminant pneumonia caused by Stenotrophomonas maltophilia (1997) (40)
- Chromosomes and causation of human cancer and leukemia. VI. Blastic phase, cellular origin, and the Ph1 in CML (1971) (40)
- Mechanisms of growth factor expression in acute myeloid leukemia (AML). (1990) (39)
- Clinical and prognostic significance of the Philadelphia chromosome in adult patients with acute lymphoblastic leukemia (1992) (39)
- Cilengitide inhibits proliferation and differentiation of human endothelial progenitor cells in vitro. (2006) (38)
- Multicentre study on intensified remission induction therapy for acute myeloid leukemia. (1982) (38)
- Chromosomes and causation of human cancer and leukemia. VII. The significance of the Ph1 in conditions other than CML (1971) (36)
- Removal of abnormal clone of leukaemic cells by splenectomy. (1975) (36)
- A Randomized Phase III Study Comparing Weekly Folinic Acid(FA) and High-Dose 5-Fluorouracil (5-FU) with Monthly 5-FU/FA (days 1-5) in Untreated Patients with Metastatic Colorectal Carcinoma (1998) (36)
- Chromosome studies in acute leukemias developing in patients with multiple myeloma. (1975) (35)
- Randomized Comparison of Interferon-a With Busulfan and Hydroxyurea in Chronic Myelogenous Leukemia (2002) (34)
- Phase I/II trial of bortezomib in patients with unresectable hepatocellular carcinoma (HCC). (2004) (34)
- Randomized phase II study of single-agent epirubicin +/— verapamil in patients with advanced metastatic breast cancer: An AIO clinical trial (1993) (34)
- Comparison of chromosome analysis and BCL‐1 rearrangement in a series of patients with multiple myeloma (1992) (34)
- Mobilization of hematopoietic progenitor cells in patients with liver cirrhosis. (2010) (34)
- Prognostic significance of chromosome analysis in de novo acute myeloid leukemia. (1990) (33)
- Randomized Comparison of Imatinib 800 Mg Vs. Imatinib 400 Mg +/- IFN in Newly Diagnosed BCR/ABL Positive Chronic Phase CML: Analysis of Molecular Remission at 12 Months; The German CML-Study IV. (2009) (32)
- Cytogenetic analyses in 89 patients with secondary hematologic disorders--results of a cooperative study. (1987) (30)
- Correlations between karyotype and cytologic findings in multiple myeloma. (1995) (30)
- Mobilization of putative high-proliferative-potential endothelial colony-forming cells during antihypertensive treatment in patients with essential hypertension. (2007) (30)
- Patients with solid tumors treated with high-temperature whole body hyperthermia show a redistribution of naive/memory T-cell subtypes. (2006) (30)
- The Local Cytokine and Chemokine Milieu within Malignant Effusions (2008) (29)
- Infusion of tumor-contaminated bone marrow for autologous rescue after high-dose therapy leading to long-term remission in a patient with relapsed Philadelphia chromosome-positive acute lymphoblastic leukemia. (1995) (28)
- A novel population of repair cells identified in the stroma of the human cornea. (2007) (28)
- A Pilot Study of Docetaxel and Trofosfamide as Second-Line ‘Metronomic’ Chemotherapy in the Treatment of Metastatic Non-Small Cell Lung Cancer (NSCLC) (2008) (27)
- 3p21 is a recurrent treatment-related breakpoint in myelodysplastic syndrome and acute myeloid leukemia. (1996) (27)
- Chromosome 14q+ in a retinoblastoma (1978) (27)
- Origin of stroma cells in long-term bone marrow cultures from patients with acute myeloid leukemia (1999) (27)
- Treatment of mantle-cell lymphomas with intermittent two-hour infusion of cladribine as first-line therapy or in first relapse. (1999) (26)
- Translocation (14; 18) and (8; 22) in three patients with acute leukemia/lymphoma following centrocytic/centroblastic non-Hodgkin's lymphoma (1991) (26)
- Pharmacokinetics of undiluted or diluted high-dose etoposide with or without busulfan administered to patients with hematologic malignancies. (1994) (26)
- The MDR phenotype in hematologic malignancies: prognostic relevance and future perspectives (1996) (26)
- Cytogenetic and clinicobiological features of acute leukemia with stem cell phenotype: study of nine cases. (1996) (26)
- No evidence of significant activity of the multidrug resistance gene product in primary human breast cancer. (1998) (25)
- Downregulation of VEGF-A, STAT5 and AKT in acute myeloid leukemia blasts of patients treated with SU5416 (2006) (25)
- Randomized clinical trial comparing mitoxantrone with epirubicin and with doxorubicin, each combined with cyclophosphamide in the first-line treatment of patients with metastatic breast cancer. (1990) (25)
- Enhanced platelet aggregation with TRAP-6 and collagen in platelet aggregometry in patients with venous thromboembolism. (2002) (25)
- Lactic acidosis and hypoglycemia in a patient with high-grade non-Hodgkin's lymphoma and elevated circulating TNF-α (1996) (25)
- IgM myeloma: a report of four cases (2002) (24)
- Role of angiogenesis inhibitors in acute myeloid leukemia. (2001) (24)
- Cytogenetics in multiple myeloma: Are we studying the ‘right’ cells? (1990) (23)
- An in vitro study on the mechanisms of coagulation activation in acute myelogenous leukemia (AML): role of tissue factor regulation by cytotoxic drugs and GM-CSF (2004) (23)
- Double minute chromosomes: a frequent marker in leukemic patients with a previous history of malignant disease? (1982) (23)
- Case 2. Hemangioblastomas: diagnosis of von Hippel-Lindau disease and antiangiogenic treatment with SU5416. (2005) (23)
- Ph1-negative chronic myelocytic leukemia with a missing Y chromosome. (1974) (22)
- Exacerbation of antiphospholipid antibody syndrome after treatment of localized cancer: a report of two cases (2002) (22)
- Effects of Vascular Endothelial and Platelet-derived Growth Factor Receptor Inhibitors on Long-term Cultures from Normal Human Bone Marrow (2001) (21)
- Randomized study of the combination of hydroxyurea and interferon alpha versus hydroxyurea monotherapy during the chronic phase of chronic myelogenous leukemia (CML Study II). The German CML Study Group. (1996) (20)
- Chromosomes in leukemia (1977) (20)
- P-glycoprotein expression in normal and reactive bone marrows. (1993) (20)
- Docetaxel and Cisplatin as First-Line Treatment for Patients with Metastatic Esophageal Cancer: A Pilot Study (2005) (20)
- A phase II study of sequential recombinant interleukin-2 followed by dacarbazine in metastatic melanoma. (1992) (20)
- Derivation of a new hematopoietic cell line with endothelial features from a patient with transformed myeloproliferative syndrome (2000) (20)
- Intermittent 2-hour-infusion of cladribine as first-line therapy or in first relapse of progressive advanced low-grade and mantle cell lymphomas. (1999) (20)
- Pharmacokinetics of high-dose VP-16: 6-hour infusion versus 34-hour infusion. (1994) (19)
- Low-dose cytarabine: chromosomal findings suggesting its cytostatic as well as differentiating effect. (1985) (19)
- Immunophenotype of mitotic cells with clonal chromosome abnormalities demonstrating multilineage involvement in acute myeloid leukemia. (1993) (19)
- Phase I Clinical and Pharmacokinetic Study of LU103793 (Cemadotin Hydrochloride) as an Intravenous Bolus Injection in Patients with Metastatic Solid Tumors (1996) (18)
- Adjuvant chemotherapy after complete resection of non-small cell lung cancer. (2008) (18)
- Imatinib dose reduction in major molecular response of chronic myeloid leukemia: results from the German Chronic Myeloid Leukemia-Study IV (2018) (18)
- Randomized phase II study of single-agent epirubicin +/- verapamil in patients with advanced metastatic breast cancer. An AIO clinical trial. Arbeitsgemeinschaft Internistische Onkologie of the German Cancer Society. (1993) (17)
- Prognostic Subgroups: The Key Factor for Treatment Outcome in Metastatic Breast Cancer (1993) (17)
- Pharmacokinetics and pharmacodynamics of the new podophyllotoxin derivative NK 611 A study by the AIO groups PHASE-I and APOH (1996) (17)
- Molecular Response to First Line Imatinib Therapy Is Predictive for Long Term Event Free Survival in Patients with Chronic Phase Chronic Myelogenous Leukemia – An Interim Analysis of the Randomized German CML Study IV (2008) (16)
- Serum levels of Magic Roundabout protein in patients with advanced non-small cell lung cancer (NSCLC). (2005) (16)
- Chronic myeloid leukemia in the elderly: long-term results from randomized trials with interferon alpha. (2003) (16)
- Effects of Whole Body Hyperthermia (41.8°C) on the Frequency of Tumor Cells in the Peripheral Blood of Patients with Advanced Malignancies (2003) (16)
- Cytogenetic studies in malignant fibrous histiocytoma. (1997) (16)
- Gemcitabine and mitomycin C in advanced pancreatic cancer: a single-institution experience (2004) (15)
- Local and systemic sequelae of mediastinal daunorubicin extravasation in a patient with acute myelomonocytic leukemia. (1997) (15)
- Pharmacokinetic and Pharmacodynamic Study with Lobaplatin (D-19466), a New Platinum Complex, after Bolus Administration (1992) (15)
- Chimaeric cultures of human marrow stroma and murine leukaemia cells: evidence for abnormalities in the haemopoietic microenvironment in myeloid malignancies and other infiltrating marrow disorders (1995) (15)
- Chronic myeloid leukemia in the elderly: long-term results from randomized trials with interferon α (2003) (15)
- Analysis of the P53, RB/D13S25, and P16 tumor suppressor genes in marginal zone B-cell lymphoma: An interphase fluorescence in situ hybridization study. (2000) (15)
- Chemotherapy of metastatic soft tissue sarcoma with a combination of adriamycin and DTIC or adriamycin and ifosfamide. (1990) (15)
- Trisomy 4 in two cases of acute myelomonocytic leukemia. (1988) (15)
- Prediction of Molecular Response of Chronic Phase CML Patients by the EUTOS Score: Results of the Randomized CML-Study IV, (2011) (14)
- Is trisomy 11 another nonrandom chromosomal anomaly in acute nonlymphocytic leukemia and myelodysplastic syndromes? (1988) (14)
- The pharmacokinetics and toxicity of two application schedules with high-dose VP-16 in patients receiving an allogeneic bone marrow transplantation. (1996) (13)
- Acute nonlymphocytic leukemia (ANLL) with isochromosome i(17q) as the sole chromosomal anomaly: a distinct entity? (1990) (13)
- Neutrophilic leukemia accompanied by hemorrhagic diathesis: Report of two cases (1987) (13)
- Adjuvant Radio-Chemotherapy with 5-Fluorouracil and Leucovorin in Stage II and III Rectal Cancer: 12 Months vs. 6 Months of Therapy. A Study of the Association for Medical Oncology of the German Cancer Society (2000) (12)
- Weekly therapy with folinic acid and high-dose 5-fluorouracil 24-hour infusion in previously untreated patients with metastatic colorectal carcinoma. (1994) (11)
- 12p-chromosome in patients with acute myelocytic leukemia or myelodysplastic syndromes following exposure to mutagenic agents. (1986) (11)
- Chromosomes in acute lymphocytic leukemia. (1987) (11)
- Identification of chromosome anomalies in the blastic phase of chronic myelocytic leukemia (CML) by Giemsa- and quinacrine-banding techniques (1974) (11)
- The IL-6 gene but not the IL-6 receptor gene is occasionally rearranged in patients with multiple myeloma. (1990) (11)
- Absence of point mutations in a functionally important part of the extracellular domain of the c-kit proto-oncogene in a series of patients with acute myeloid leukemia (AML). (1994) (11)
- Molecular Response After 3 Months of 1st Line Imatinib Therapy Is Predictive for Treatment Failure and Disease Progression In Patients with Chronic Phase Chronic Myeloid Leukemia - a Follow-up Analysis of the German CML Study IV (2010) (11)
- Demonstration of i(17q) in metaphase and interphase of malignant hematopoietic cells by fluorescence in situ hybridization. (1994) (11)
- A clinical trial of edrecolomab, interleukin-2 and GM-CSF in patients with advanced colorectal cancer. (2001) (11)
- A Phase II combination trial with recombinant human tumor necrosis factor and gamma interferon in patients with colorectal cancer (1991) (10)
- Trisomy 8 preceding diagnosis of acute nonlymphocytic leukemia by 2 years in a patient with multiple myeloma without cytological evidence of myelodysplasia (1996) (10)
- Prolonged inhibition of von Willebrand factor‐cleaving protease after splenectomy in a 22‐year‐old patient with acute and plasma refractory thrombotic thrombocytopenic purpura (2002) (10)
- ASHAP – an effective salvage therapy for recurrent and refractory malignant lymphomas (2000) (10)
- Prognostic impact of cytogenetic aberrations in patients with multiple myeloma or monoclonal gammopathy of unknown significance (2005) (10)
- Prognostic significance of chromosome analysis in de novo acute myeloid leukemia (AML) (2004) (10)
- Toxicity, pharmacokinetics and metabolism of iododoxorubicin in cancer patients. (1990) (10)
- High-performance liquid chromatography of iodo-doxorubicin and fluorescent metabolites in plasma samples. (1990) (10)
- An ovarian thecoma with a single numerical aberration: +12. (1993) (9)
- Chronic myelogenous leukemia : recent developments in prognostic evaluation and chemotherapy (1992) (9)
- Fotemustine and interferon α2b in metastatic malignant melanoma (1998) (9)
- Indirect radiation leukemogenesis in DBA/2 mice: increased expression of B2 repeats in FDC-P1 cells transformed by intracisternal A-particle transposition (1998) (9)
- Expression of the adhesion molecules CD49d and CD49e on G-CSF-mobilized CD34+ cells of patients with solid tumors or non-Hodgkin's and Hodgkin's lymphoma and of healthy donors is inversely correlated with the amount of mobilized CD34+ cells. (1999) (9)
- Prolongation of medium exchange is associated with a decrease in function but not expression of the P‐glycoprotein pump in leukaemic cells (2009) (8)
- Novel Philadelphia variant t(Y;9;22)(q12;q34;q11) in a case of chronic myeloid leukemia. (1999) (8)
- Plasma cell dyscrasias--a comparative study of cell surface properties in plasma cell leukemia and myeloma. (1980) (8)
- Randomized Comparison of Primary Allogeneic Stem Cell Transplantation and Best Available Drug Treatment in Chronic Myeloid Leukemia. (2006) (8)
- Normal bone marrow karyotype in paroxysmal nocturnal hemoglobinuria--a cooperative European study. (1983) (8)
- Systemic therapy of disseminated soft tissue sarcomas. (1995) (8)
- Disappearance of hypotetraploid clones after short-term culture of leukemic cells. A case report. (1983) (8)
- Single-Center Management of 136 Patients with Cancer of Unknown Primary Site (CUP Syndrome) Over a Period of 10 Years (2009) (8)
- [Treatment of thrombotic thrombocytopenic purpura (Moschcowitz's disease) with vincristine]. (2008) (7)
- [Transplantation of hematopoietic stem cells. II: Indications for transplantation of hematopoietic stem cells after myeloablative therapy]. (1997) (7)
- Secondary Malignancies in CML Patients – Data From the German CML Study IV (2012) (7)
- Rectal Cancer: Integrating Oxaliplatin Into Chemoradiation Studies (2000) (7)
- Self-renewal and differentiation of stem cells in a biopotential murine leukemia: an in vitro model for differentiation therapy. (1994) (7)
- Randomized study on the treatment of chronic myeloid leukemia (CML) in chronic phase with busulfan versus hydroxyurea versus interferon-alpha (1988) (7)
- Peripheral T cells of patients with B cell non-Hodgkin's lymphoma show a shift in their memory status. (2005) (7)
- Effects of whole body hyperthermia (41.8 degrees C) on the frequency of tumor cells in the peripheral blood of patients with advanced malignancies. (2003) (7)
- Superior CMR-Rates with Tolerability-Adapted Imatinib 800 Mg Vs. 400 Mg Vs. 400 Mg + IFN In CML: The Randomized German CML-Study IV (2010) (7)
- Feasibility of Imatinib Combination Therapies in a Randomized Trial for Chronic Myeloid Leukemia: The German CML-Study IV - Pilot Phase. (2004) (7)
- Cytogenetics in multiple myeloma and plasma cell leukemia: simultaneous cytogenetic and cytologic studies in 51 patients (1992) (7)
- Treatment of Adult Metastatic Soft-Tissue Sarcoma with Doxorubicin/ Ifosfamide: Better Hematologic Tolerance by G-CSF? (1996) (7)
- Multidrug Resistance (mdr1) in Adult Acute Leukemia at Diagnosis: Correlation with Response to Induction Chemotherapy (1993) (6)
- Absence of point mutations in the extracellular domain of the alpha subunit of the GM-CSF receptor in a series of patients with acute myeloid leukemia (AML). (1995) (6)
- Leukemic nodules at the site of G‐CSF injection in acute myelomonocytic leukemia (1995) (6)
- Neurotoxicity following weekly therapy with folinic acid and high-dose 5-fluorouracil 24-h infusion in patients with gastrointestinal malignancies. (1993) (6)
- GCSF gene is expressed but not rearranged in a patient with isochromosome 17q positive acute nonlymphocytic leukemia. (1993) (6)
- [Diagnosis and spontaneous course of liver metastases]. (1991) (5)
- Complete Molecular Remission (CMR 4.5) of CML Is Induced Faster by Dose – Optimized Imatinib and Predicts Better Survival - Results From the Randomized CML-Study IV (2012) (5)
- UFT/leucovorin plus weekly irinotecan in advanced or metastatic colorectal cancer. (2000) (5)
- Optimaization of Imatinib Therapy by Combination. 5 Year Survival and Response Results of the Pilot Phase of the Randomized German CML STUDY IV. (2009) (5)
- Translocation (2;4)(p23;q25): an additional case of a new recurrent anomaly in acute myeloid leukemia. (1993) (5)
- [The results of a modified FAMeth chemotherapy protocol in metastatic stomach carcinoma]. (2008) (5)
- t(1;19)(q23;p13) in a case of acute monocytic leukemia. (1996) (5)
- VEROTOXIN IN THROMBOTIC THROMBOCYTOPENIC PURPURA (1989) (5)
- Immunophenotype of Abnormal Metaphases Demonstrating Multilineage Involvement in Myelodysplastic Syndromes. (1990) (5)
- Fotemustine and interferon alpha2b in metastatic malignant melanoma. (1998) (5)
- Allogeneic transplantation with CD34+-selected cells. (1997) (5)
- Deletion of chromosome 15 represents a rare but recurrent chromosomal abnormality in myelocytic malignancies (2003) (5)
- Deletion of chromosome 15 represents a rare but recurrent chromosomal abnormality in myelocytic malignancies. (2003) (5)
- Necrotizing glomerulonephritis associated with Hodgkin's disease. (2001) (5)
- Chronic myelocytic leukemia: cytogenetic findings and their relations to pathogenesis and clinic. (1975) (5)
- Treatment results obtained in metastatic soft-tissue sarcoma with a combination of doxorubicin and dacarbazine or doxorubicin and ifosfamide. (1993) (5)
- A phase II study of irinotecan (CPT-11) and carboplatin in patients with limited disease small cell lung cancer (SCLC). (2007) (5)
- Cytogenetics in leukemia: implications for pathogenesis and prognosis. (1984) (5)
- Alteration in Epirubicin Pharmacokinetics and Metabolism by Dexverapamil: Results from a Phase II Study in Patients with Metastatic Breast Cancer (1999) (5)
- Pharmacokinetics of Doxorubicin in the Heparinized Perfusate during Isolated Hyperthermic Limb Perfusion (1993) (4)
- AN IDENTICAL TRANSLOCATION t(1;20) (q12.3;p13) IN TWO PATIENTS WITH MULTIPLE MYELOMA (1990) (4)
- Increased toxicity of tumor necrosis factor/gamma interferon in patients with leukocytosis. (1988) (4)
- Reinterpretation of G‐banded complex karyotypes by fluorescence in situ hybridization with chromosome‐specific DNA painting probes and alpha‐satellite centromere‐specific DNA probes in malignant hematological disorders (1997) (4)
- [Possible prevention of adriamycin-induced cardiomyopathy by verapamil. Results of a pilot study]. (1984) (4)
- Explaining survival differences between two consecutive studies with allogeneic stem cell transplantation in patients with chronic myeloid leukemia (2014) (4)
- Hematopoietic growth factors and the treatment of tumor-associated anemias (1994) (4)
- Exposure to lipophilic industrial solvents leads to increased P‐glycoprotein expression in peripheral blood cells (1993) (4)
- Tissue disposition and plasma concentrations of idarubicin after intravesical therapy in patients with bladder tumors (2004) (4)
- Proceedings: An appraisal of cytogenetics in leukemia, including a correlation with the evolution and prognosis of acute leukemia. (1972) (4)
- GM‐CSF in busulfan overdosage (1990) (4)
- A case of adult ALL with +i(13q) as the sole anomaly. (1992) (4)
- [Transplantation of hematopoietic stem cells. I: Definitions, principle indications, complications]. (1997) (4)
- Unusual clinical course and acquisition of del(11)(q23) in second lymphatic blastic phase of a Ph-positive chronic myeloid leukemia. (1999) (4)
- Randomized studies with interferon in chronic myelogenous leukemia (CML) and comparative molecular aspects. German CML Study Group. (1997) (4)
- Difficult Diagnostic Cases (2016) (3)
- Identification of some marker chromosomes in acute leukemias by fluorescence in situ hybridization (1993) (3)
- Determination of the new podophyllotoxin derivative NK 611 in plasma by high-performance liquid chromatography with ultraviolet detection. (1993) (3)
- Role of mature leukemic cells in the amplification of leukemic stem cells in a murine model (1995) (3)
- [Addition of hyperthermia. Heat potentiates cancer therapy]. (2001) (3)
- High-Risk Additional Chromosomal Abnormalities in CML Herald Death By Blast Crisis Already at Low Blast Levels (2019) (3)
- Treatment of patients with refractory, C-KIT positive, acute myeloid leukemia with SU5416, a novel receptor tyrosine kinase inhibitor (2001) (3)
- The Role of Maintenance Chemotherapy, Immunotherapy, Induction Dose Reduction in Elderly Patients and Double Induction in the Treatment of Adult Acute Myeloid Leukemia. Four Randomized Studies of the AML Cooperative Group1 (1989) (3)
- Metastasectomy following Chemotherapy in Patients with Advanced Soft Tissue Sarcomas (1992) (3)
- Incidence and treatment of fungal infections in neutropenic patients. (1987) (3)
- Polysomy 13 with concomitant deletion of 13q13-14 involving the retinoblastoma gene and the D13S25 locus in a case of acute myeloid leukemia. (2000) (3)
- A randomised phase II study of gemcitabine versus mitomycin C versus gemcitabine/mitomycin C in patients with advanced pancreatic cancer (2008) (3)
- ider(9)(q10)t(9;22)(q34;q11) is a recurrent chromosomal abnormality in acute lymphoblastic leukemia and lymphatic blastic phase of chronic myelogenous leukemia. (1996) (3)
- Cytogenetic Studies in Patients with Acute Myeloid Leukemia Following a Myelodysplastic Syndrome. (1991) (3)
- Polychemotherapy with methotrexate in medium dose range, 5-fluorouracil and adriamycin in advanced gastric carcinoma (1986) (3)
- Treatment of acute myeloid leukemia and myelodysplastic syndrome by low dose cytosine arabinoside. (1985) (3)
- Chronic myelogenous leukemia: recent developments in prognostic evaluation and chemotherapy. The German CML Study Group. (1992) (2)
- Pharmacodynamic and pharmacokinetic aspects of iodo-doxorubicin. (1992) (2)
- Second Line Therapy with Second Generation TKI After Intolerance to Imatinib Based Treatments Showed High Overall Survival in Contrast to Second Line Therapy After Resistance; Results of the Randomized CML Study IV (2011) (2)
- 754 5-FU/FA IV bolus therapy vs weekly high-dose 5-FU/FA 24-hour infusion in metastatic colorectal carcinoma: Preliminary results of an ongoing randomized phase III study (1995) (2)
- Dose Intensity of Chemotherapy in Breast Cancer. Results of Clinical Studies (1995) (2)
- Salvage Chemotherapy with Dacarbazine or Carboplatin/VP-16 of Advanced Soft Tissue Sarcoma Pre-treated with Doxorubicin/lfosfamide (1996) (2)
- Treatment of metastatic gastric carcinoma with a modified FAMTX chemotherapy regimen. (1990) (2)
- ASSESSMENT OF IMATINIB 400MG AS FIRST LINE TREATMENT OF CHRONIC MYELOID LEUKEMIA: 10-YEAR SURVIVAL RESULTS OF THE RANDOMIZED CML STUDY IV (2017) (2)
- management and outcome of Cml-blast crisis: Results from the randomized Cml study Iv : V907 (2014) (2)
- Characterization of the genes rearranged in the t(11;18) (q21; q21) associated with MALT lymphomas (1999) (2)
- Occurrence of the common acute lymphoblastic leukemia antigen on blast cells of a patient with chronic myelomonocytic leukemia in non-lymphoid blastic phase. (1985) (2)
- Malignant progression of angioimmunoblastic lymphadenopathy (1979) (2)
- Treatment of Patients with Refractory AML with SU5416 Downregulates VEGF-A, STAT5 and Akt Expression in Leukemic Blasts. (2005) (2)
- [Immunosuppressive treatment of a spontaneous inhibitor hemophilia A using cyclophosphamide, vincristine and prednisone following prior Factor VIII stimulation]. (1996) (2)
- Phase I Study with Iodo-Doxorubicin (1989) (2)
- Malignant Lymphoma and Multiple Myeloma (1994) (2)
- Low-dose cytosine-arabinoside in the treatment of acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) (1984) (2)
- Occurrence of the common acute lymphoblastic leukemia antigen on blast cells of a patient with chronic myelomonocytic leukemia in non-lymphoid blastic phase (1985) (2)
- Dicentric (19;21)(p13;p13), a novel chromosomal abnormality occurring in a case of Philadelphia chromosome-positive acute lymphoblastic leukemia. (2004) (2)
- Shedding of tnf-receptor and soluble icam-1 molecules in response to treatment with recombinant tnf-alpha and IFN-gamma in patients with colorectal-cancer. (1994) (2)
- T-cell acute lymphoblastic leukemia with translocation (1;18). (1988) (2)
- Therapy with Imatinib In Elderly CML Patients (>65years): Results of the German CML-Study IV. (2010) (2)
- Pharmacogenetics of Extraordinary Responses to 5-FU/Cisplatin Chemotherapy in Advanced Gastric Cancer – Report of 2 Cases (2005) (2)
- Dic (19;21) (p13;p13), a novel chromosomal abnormality occurring in a case of Philadelphia chromosome positive ALL. (2000) (1)
- A subtype of the prototypic karyotype in acute myeloid leukemia t (8; 21) (q22; q22), del 9 (q13; q23) (2005) (1)
- [Relations between chromosomal findings and prognosis in acute nonlymphoblastic leukemia (author's transl)]. (1979) (1)
- Molecular cytogenetic characterization of the chromosome 11 and 18 breakpoints in the t(11;18)(q21;q21) associated with malt lymphomas (1998) (1)
- Chemotherapy of Metastatic Malignant Melanoma with Cis-Platinum/Ifosfamide or Cis-Platinum/Actinomycin D (1987) (1)
- Effects of Whole Body Hyperthermia ( 41 . 8 ° C ) on the Frequency of Tumor Cells in the Peripheral Blood of Patients with Advanced Malignancies 1 (2003) (1)
- High-Dose Chemotherapy with Busulfan, Cyclophosphamide, and VP-16 as Conditioning for Allogeneic and Autologous Bone Marrow Transplantation for Patients with Acute Myeloid Leukemia (1997) (1)
- Pretreatment Expression Levels of MDR1 and OCT-1 Predict Response to First Line Imatinib Treatment In Chronic Phase CML Patients (2010) (1)
- Workshop ‘Psychoneuroimmunology in Relation to Cancer’ vom 3.-7. Juni 1990 in Tutzing (1990) (1)
- 10-year survival with imatinib: final evaluation of randomized CML-study (2017) (1)
- Pulmonary Toxicity of Highland Intermediate-Dose Cytosine Arabinoside Therapy: A Retrospective Analysis (1994) (1)
- Increased formation of DNA adducts in cultured fibroblasts of patients with aplastic anemia after in vitro incubation with benzo(a)pyrene (1990) (1)
- [Complicated antiphospholid antibody syndrome]. (2002) (1)
- Prognostic Factors Identified Via a Cox Proportional Hazard Cure Model Explain Survival Differences After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in Chronic Myeloid Leukemia (CML) Between Two Consecutive Patient Cohorts (2012) (1)
- Translocation t (4; 11) in acute lymphocytic leukemia (ALL) (1982) (1)
- Expression of vascular endothelial growth factor (VEGF) and its receptors KDR and flt during melanoma progression (2007) (1)
- 866 Combination of doxorubicin/ifosfamide ± G-CSF in adult metastatic soft tissue sarcoma (STS) (1995) (1)
- Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) with a Related Donor in Chronic Myeloid Leukemia (CML): An Explanation for Fast Improvement of Survival in Two Consecutive German CML Studies. (2009) (1)
- The Prognostic Impact of Trisomy 8 in Acute Myeloid Leukemia: Do Accompanying Aberrations Influence Prognosis? (1998) (1)
- Coating of intracoronary stents with AC133+ endothelial progenitor cells (2003) (1)
- Polysomy 13 with deletion of the retinoblastoma gene and the D13S25 locus in a case of acute myeloid leukemia (1998) (1)
- Additional chromosomal indication for the unicellular origin of chronic myelocytic leukemia (1975) (1)
- [Prevalence of hepatitis C virus in poly-transfused patients with hematologic and oncologic diseases]. (1992) (1)
- Incidence and prognostic significance of deletions of tumor suppressor genes and aneuploidies in multiple myeloma: an interphase FISH study (2001) (1)
- Pharmacokinetics and toxicity of dexniguldipine after single and repetitive daily 4 h infusions in cancer patients: 104 (1994) (1)
- Tnf-alpha induces gm-csf secretion in leukemic-cell lines u-937 and kg-1a. (1995) (1)
- The chromosome 18 breakpoint in the t(11;18)(q21;q21) associated with MALT lymphomas lies proximal to BCL2 (1998) (0)
- The genetic profile of marginal zone B-cell lymphoma (1999) (0)
- Ten-year survival after randomized comparison of imatinib (IM) 400 mg vs. IM 800 mg vs. IM + IFN vs. IM + Ara C vs. IM after IFN in chronic myeloid leukemia (CML). (2017) (0)
- Ex-Vivo Expansion of Multipotent CD133+ Stem Cells with VEGF, FLT3l and SCGF. (2004) (0)
- Expression of NK-associated surface-antigens cd-56 and cd-16 on aml-cells. (1994) (0)
- Correlation of pre-treatment serum levels of Magic Roundabout protein with overall survival in patients with advanced non-small cell lung cancer (NSCLC) (2005) (0)
- Pilot phase ii study of high dose epirubicin and high dose verapamil in metastatic breast cancer patients toxicity response rate and pharmacokinetics (1989) (0)
- Decreased cardiotoxicity of adriamycin by verapamil (1986) (0)
- Pancreatic tumor growth is regulated by the balance of positive and negative modulators of angiogenesis (2001) (0)
- Response: Drug treatment and allografting as first-line therapy in young patients with CML (2007) (0)
- Therapeutic and Prognostic Factors in the Management of Acute Myeloid Leukemia (1997) (0)
- myeloid leukemia A phase II clinical study of SU5416 in patients with refractory acute (2013) (0)
- Analysis of tumor suppressor genes in marginal zone B-cell lymphomas: An interphase fish study (1998) (0)
- Helix pomatia agglutinin (HPA) binding: an independent prognostic factor in resected adenocarcinomas of the lung (2001) (0)
- Intensive-Dose Epirubicin with and without High-Dose Verapamil: Toxicity, Pharmacokinetics, Metabolism and Response in Pretreated Patients with Metastatic Breast Cancer (1989) (0)
- Whole body hyperthermia (WHB, 41.8°C) in combination with chemotherapy in gastrointestinal (GI) cancer (1999) (0)
- Burkitt's lymphoma-associated translocations in multiple myeloma and plasma cell leukemia (1998) (0)
- myeloid leukemia Drug treatment is superior to allografting as first-line therapy in chronic (2013) (0)
- Pharmacokinetics of irinotecan (CPT-11) in wildtype-and P-glycoprotein- (P-gp) knockout (mdr1a/1b (−/−)) mice (2001) (0)
- Terminal deoxynucleotidyl transferase (TdT) and membrane receptors in human leukemia and lymphoma — First experience with lyophilized cells (1981) (0)
- [Prospective controlled study of therapy of chronic myeloid leukemia (CML)]. (1987) (0)
- A pilot study of weekly docetaxel and daily trofosfamide as metronomic second-line chemotherapy in the treatment of metastatic non-small cell lung cancer (NSCLC) (2016) (0)
- Treatment results in patients with disseminated soft tissue sarcomas with Adriamycin/DTIC and Ifosfamid/Cisplatin (1986) (0)
- Interferon-α in the Treatment of CML: Comparison of Busulfan versus Hydroxyurea versus Interferon-α (1994) (0)
- Extramedullary manifestation of the blastic phase of chronic myelocytic leukemia: A chromosome study (1975) (0)
- Interferon-α-2b + fotemustine in disseminated malignant melanoma (1994) (0)
- Dmg treatment is superior to allografting as first-line therapy in chronic myeloid leukemia. Commentary (2007) (0)
- Author reply (0)
- naive/memory T-cell subtypes whole body hyperthermia show a redistribution of Patients with solid tumors treated with high-temperature (2016) (0)
- Discontinued at Least 90 Days Before the Procedure Myelogenous Leukemia Does Not Affect Outcome Adversely, Provided It Is Interferon-? Before Allogeneic Bone Marrow Transplantation in Chronic (2013) (0)
- A pilot study of recombinant human TNF and interferon‐gamma in four patients with refractory AML (1992) (0)
- Contents, Vol. 19, 1977 (1977) (0)
- Process for ex vivo expansion and differentiation of multipotent stem cells (2001) (0)
- Subject Index Vol. 32, 2009 (2009) (0)
- No more transplantation in CML? Authors' reply (2007) (0)
- Expression of Cancer/Testis Antigens CT10 and SSX in Multiple Myeloma: Promising Targets for Antigen-Specific Immunotherapy. (2005) (0)
- Role and Extent of Surgery in Multimodality Treatment (1999) (0)
- Editorial (2000) (0)
- Novel Philadelphia variant translocation t(Y;9;22) (q12;q34;q11) in a case of CML (1998) (0)
- Chemotherapy of metastatic malignant melanoma by cisplatin/ifosfamid or cisplatin / actinomycin d (1986) (0)
- [Chromosome analysis of solid tumors and its value in clinical medicine and research]. (1990) (0)
- Analysis of the P53 , RB and P16 tumor suppressor genes in marginal zone B-cell lymphomas: an interphase fish study (1998) (0)
- Chromosomal gains and losses are rare in hairy cell leukemia: a study based on comparative genomic hybridization and interphase FISH (2000) (0)
- Major Route Additional Chromosomal Aberrations (ACA) Precede Increase of Blasts in CML: An Analysis of the German CML-Studies III and IIIA (2015) (0)
- Deletions of the region 1p36.3 are uncommon in marginal zone B-cell lymphomas: an interphase fish study (1999) (0)
- Unusual clinical course and acquisition of del (11) (q23) in second lymphatic elastic phase of a Ph+ CML (1998) (0)
- Drug treatment or stem cell transplantation as primary treatment for patients with CML (2007) (0)
- The function of the P-glycoprotein (P-gp) pump decreases under deteriorating growth conditions: implications for daunorubicin (DNR) accumulation studies in leukemic cells (1994) (0)
- Cytostatic Anticancer Drug Development: Preclinical Studies and Early Clinical Trials (1990) (0)
- Cytostatic Anticancer Drug Development: Preclinical Studies and Early Clinical Trials (1990) (0)
- Immunophenotype of Abnormal Me taphases Demonstrating Multilineage Involvement in M yelodysplastic Syndromes (1990) (0)
- Subject Index Vol. 19, 1977 (1977) (0)
- Fluorescence In Situ Hybridization (FISH): A Powerful Method for the Detection of Genetic Abnormalities in Metaphases and in Interphase Nuclei (1999) (0)
- ALL of Burkitt's type (L3) showing a Complex Karyotype including translocations t(14;18) (q32;q21) and t(3;8) (q27;q24) with BCL2 and BCL6 involvement. (2000) (0)
- Short communication Dicentric (19;21)(p13;p13), a novel chromosomal abnormality occurring in a case of Philadelphia chromosome-positive acute lymphoblastic leukemia (2004) (0)
- Prognostic significance of the karyotype in patients with primary myelodysplastic syndrome. (1990) (0)
- Wilke H, et al.: Phase II study with folinic acid, etoposide, 5-fluorouracil and cisplatin (FLEP) for advanced gastric cancer. Onkologie 1994;17:154-157 (this issue) (1994) (0)
- Aclacinomycin A/Etoposide Combination Therapy for Advanced Relapsed Acute Myeloid Leukemia: Results of a Pilot Study of the Arbeitsgemeinschaft Internistische Onkologie (1990) (0)
- Chromosome Findings in Secondary Acute Leukemias (1985) (0)
- [Chromosomal behavior in human neoplastic diseases]. (1972) (0)
- The Tyrosine Kinase src Is Highly Activated in AML and Plays a Crucial Role in Leukemic Cell Proliferation. (2005) (0)
- Chemotherapy for Adult Acute Myeloid Leukemia: Study Results from the Acute Myeloid Leukemia Cooperative Group and Overview (1993) (0)
- [Iodo-doxorubicin, a new anthracycline derivative. Current state of progress]. (1990) (0)
- Bleeding Complication following Tooth Extraction in a Hemophilia A Patient with Inhibitor — A Case Report (2003) (0)
- P-492 Pretreatment serum level of VEGF — an independent prognostic factor in metastatic non-small cell lung cancer (NSCLC) (2003) (0)
- The Pattern Of Cytogenetic Aberrations In CML BC Stratified For Treatment (2013) (0)
- Neoplastic Diseases of the Blood (2005) (0)
- Contents Vol. 32, 2009 (2009) (0)
- Expression o f C EACAM1 i n A denocarcinoma o f t he L ung: A F actor o f I ndependent P rognostic S ignificance (2002) (0)
- Reinterpretation of G-banding complex karyotypes by fluorescence in situ hybridization with chromosome-specific DNA libraries and alpha-satellite centromere-specific DNA probes in malignant hematological disorders (1995) (0)
- Interferon α‐2b + fotemustine in disseminated malignant melanoma (DMM): 187 (1993) (0)
- Different treatment strategies in patients with metastatic bladder cancer (1986) (0)
- The genes of the alpha-chain and Beta-chain of the gm-csp receptor are not rearranged in patients with aml. (1994) (0)
- Mitoxantron and cyclophosphamid as second line chemotherapy in disseminated breast cancer (1986) (0)
- Endostatin Inhibits VEGF-Induced Lung Edema by Reducing Vascular Permeability. (2004) (0)
- Book Reviews (1898) (0)
- No Adverse Impact of 13q14 and P53 Deletion, t(4;14)(p16;q32) or Overrepresentation of CMYC(8q24) as Detected by Fluorescence In Situ Hybridization on Outcome in Patients with Multiple Myeloma Following Dose-Reduced Allogeneic Stem Cell Transplantation. (2006) (0)
- Fotemustine with or without interferon a 2b in the treatment of advanced malignant melanoma. A comparison of two clinical trials (1993) (0)
- A cytogenetical analysis in patients with secondary hematological disorders. (1987) (0)
- [Multicenter prospective controlled study of therapy of chronic myeloid leukemia. Comparison of busulfan, hydroxyurea and interferon alpha (April 1990 status)]. (1991) (0)
- Phase I-II study of interferon-gamma and eflornithine (DFMO) in patients with advanced renal cell carcinoma, malignant melanoma and colorectal carcinoma. (1996) (0)
- High age and high frequency of treatment switch in CML patients outside of clinical trials: interim results of the German CML VI trial (2017) (0)
- Phase II Trial of S-Fluorouracil and Recombinant Interferon Alfa-2B in Metastatic Carcinoma Colorectal (1992) (0)
- PROSPECTIVE MULTICENTER STUDY FOR TREATMENT OF CHRONIC MYELOCYTIC-LEUKEMIA - COMPARISON OF BUSULFAN, HYDROCYUREA AND INTERFERON ALPHA (UPDATE APRIL, 1990) (1991) (0)
- Cytogenetic analysis in chondrosarcoma (2007) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Dieter‐kurt Hossfeld?
Dieter‐kurt Hossfeld is affiliated with the following schools:
